EP2649086
Notkun á blendingsmótefnavakaviðtaka-breyttum T-frumum til að meðhöndla krabbamein
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.12.2011EP published:
19.7.2017EP application number:
11846757.0
EP translation filed:
11.10.2017Grant published:
15.11.2017EPO information:
European Patent Register
Max expiry date:
8.12.2031Expiry date:
8.12.2026Next due date:
31.12.2026
Title:
USE OF CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS TO TREAT CANCER
Timeline
Today
9.12.2011EP application
19.7.2017EP Publication
11.10.2017Translation submitted
15.11.2017Registration published
8.12.2026Expires
Owner
Name:
The Trustees of The University of PennsylvaniaAddress:
Center for Technology Transfer 3160 Chestnut Street, Suite 200, 19104-6283, Philadelphia , PA, US
Inventor
Name:
JUNE, Carl, H.Address:
Merion Station, PA, US
Name:
LEVINE, Bruce, L.Address:
Cherry Hill, NJ, US
Name:
PORTER, David, L.Address:
Springfield, PA, US
Name:
KALOS, Michael, D.Address:
Philadelphia, PA, US
Name:
MILONE, Michael C.Address:
Cherry Hill, NJ, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161502649 PDate:
29.6.2011Country:
US
Number:
421470 PDate:
9.12.2010Country:
US
Supplementary protection
SPC number:
SPC254
Classification
Categories:
A61K 39/00, A61K 35/17
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 12.12.2017
Expires: 8.12.2018
Payer: Árnason Faktor
Number: 8
Paid: 26.11.2018
Expires: 8.12.2019
Payer: Árnason Faktor
Number: 9
Paid: 26.11.2019
Expires: 8.12.2020
Payer: Árnason Faktor
Number: 10
Paid: 24.11.2020
Expires: 8.12.2021
Payer: Árnason Faktor ehf.
Number: 11
Paid: 6.12.2021
Expires: 8.12.2022
Payer: Árnason Faktor ehf.
Number: 12
Paid: 13.12.2022
Expires: 8.12.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 29.11.2023
Expires: 8.12.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 28.11.2024
Expires: 8.12.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 29.12.2025
Expires: 8.12.2026
Payer: Árnason Faktor ehf.